January 23, 2008 8:00am EST
Download as PDF
MIAMI, Jan. 23 /PRNewswire-FirstCall/ -- OPKO Health, Inc. (Amex: OPK)
today announced that it will present at the 2008 Wachovia Healthcare
Conference on Wednesday, January 30, 2008 at 11:15 am EST. The conference
will be held at the Langham Hotel in Boston.
OPKO senior management will provide a review of recent corporate
developments.
A live audio webcast and replay of the company's presentation will be
available at the Investor Relations section of the company's website at
www.opko.com .
About OPKO Health, Inc.
Miami-based OPKO is a specialty healthcare company. Its lead
investigational drug, the pioneering gene silencing agent bevasiranib, has
entered a pivotal Phase III trial after successfully completing Phase II
trials for wet age-related macular degeneration and diabetic macular edema.
OPKO is developing a pipeline of novel agents for ophthalmic diseases, and it
markets innovative diagnostic imaging systems that complement the company's
therapeutic products. For more information visit the company's website at
www.opko.com .
Corporate: GendeLLindheim BioCom Partners
Steven D. Rubin Barbara Lindheim
305 575-6000 212 918-4650
SOURCE OPKO Health, Inc.
Released January 23, 2008
email Email Alerts
location_city Company Profile
contact_page Contacts
rss_feed RSS News Feed
account_tree Sitemap
Apply on OPKO Health (Ireland)’s careers page